Home / Petrochemicals / Venous Thromboembolism Global Clinical Trials Review, H1, 2015

Venous Thromboembolism Global Clinical Trials Review, H1, 2015

Published: Apr 2015 | No Of Pages: 107 | Published By: GlobalData

Venous Thromboembolism Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2015" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Venous Thromboembolism 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Venous Thromboembolism 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
C. H. Boehringer Sohn AG & Co. KG 34
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 34
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Sanofi 44
Clinical Trial Overview of Sanofi 44
Astellas Pharma Inc. 46
Clinical Trial Overview of Astellas Pharma Inc. 46
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Bristol-Myers Squibb Company 50
Clinical Trial Overview of Bristol-Myers Squibb Company 50
Daiichi Sankyo Company, Limited 52
Clinical Trial Overview of Daiichi Sankyo Company, Limited 52
AstraZeneca PLC 54
Clinical Trial Overview of AstraZeneca PLC 54
Johnson & Johnson 56
Clinical Trial Overview of Johnson & Johnson 56
Clinical Trial Overview of Top Institutes / Government 57
McMaster University 57
Clinical Trial Overview of McMaster University 57
Hamilton Health Sciences 58
Clinical Trial Overview of Hamilton Health Sciences 58
Ottawa Hospital Research Institute 59
Clinical Trial Overview of Ottawa Hospital Research Institute 59
The Utrecht Institute for Pharmaceutical Sciences 60
Clinical Trial Overview of The Utrecht Institute for Pharmaceutical Sciences 60
Universita degli Studi dell'Insubria 61
Clinical Trial Overview of Universita degli Studi dell'Insubria 61
Capital District Health Authority, Canada 62
Clinical Trial Overview of Capital District Health Authority, Canada 62
Centre Hospitalier Universitaire de Grenoble 63
Clinical Trial Overview of Centre Hospitalier Universitaire de Grenoble 63
Hadassah Medical Organization 64
Clinical Trial Overview of Hadassah Medical Organization 64
Juntendo University School of Medicine 65
Clinical Trial Overview of Juntendo University School of Medicine 65
Leiden University Medical Center 66
Clinical Trial Overview of Leiden University Medical Center 66
Five Key Clinical Profiles 67
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107

List of Tables
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Region, 2015* 7
Venous Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Venous Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Venous Thromboembolism Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Venous Thromboembolism Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Venous Thromboembolism Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Venous Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 34
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 42
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 44
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 46
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 48
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 50
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 52
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 54
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 56
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 57
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2015* 58
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015* 59
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The Utrecht Institute for Pharmaceutical Sciences, 2015* 60
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi dell'Insubria, 2015* 61
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 62
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Grenoble, 2015* 63
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015* 64
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 65
Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 66

List of Figures
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Venous Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Venous Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Venous Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Venous Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 106

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +